May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Time Dependent Changes in Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS)
Author Affiliations & Notes
  • J.D. Brandt
    Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, CA
  • J.A. Beiser
    Department of Ophthalmology & Visual Sciences, Washington University, St. Louis, MO
  • M.O. Gordon
    Department of Ophthalmology & Visual Sciences, Washington University, St. Louis, MO
  • S.C. Lin
    Department of Ophthalmology, Univ of California San Francisco, San Francisco, CA
  • M.Y. Alexander
    Kresge Eye Institute, Wayne State University, Detroit, MI
  • M.A. Kass
    Department of Ophthalmology & Visual Sciences, Washington University, St. Louis, MO
  • OHTS Study Group
    Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, CA
  • Footnotes
    Commercial Relationships  J.D. Brandt, None; J.A. Beiser, None; M.O. Gordon, None; S.C. Lin, None; M.Y. Alexander, None; M.A. Kass, None.
  • Footnotes
    Support  NIH Grants EY10376, EY09341 & EY09307; Merck Research Labs; Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4422. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.D. Brandt, J.A. Beiser, M.O. Gordon, S.C. Lin, M.Y. Alexander, M.A. Kass, OHTS Study Group; Time Dependent Changes in Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS) . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4422.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare baseline central corneal thickness (CCT) to repeat measures performed an average of 3.8 years later.

Methods: : First and second CCT measurements were performed using an ultrasonic pachymeter with the same protocol. First and second CCT measurements were completed for 76% of 1,636 participants. By the time of the second CCT measurement, participants originally randomized to observation had been on topical hypotensive medications for a mean of 12 months. Medication exposure was calculated by adding the number of medications multiplied by months of usage. Participants who had undergone incisional intraocular or keratorefractive surgery were excluded from this analysis.

Conclusions: : The rate of CCT thinning over 3.8 years is comparable to the cross–sectional age differences reported in OHTS at the first measurement (0.6 µM/year) and comparable to other cross–sectional studies. Use of topical medications, in particular topical prostaglandin analogues, may be associated with a slightly higher rate of thinning. The modest age– and drug–related rates of thinning described are unlikely to influence tonometry or clinical decision–making.

Keywords: clinical (human) or epidemiologic studies: risk factor assessment • intraocular pressure • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×